Key Takeaways:
- What is gene therapy? Gene therapy uses one of several techniques to correct malfunctioning or dysfunctional genes related to hearing.
- How your genes are involved in hearing: Genes provide instructions for inner ear cells to detect sound and send signals to the brain. A genetic variant can affect this process, and genetic testing can identify which gene(s) may not be working properly.
- How gene therapy works: Gene therapy can involve gene addition, gene editing, or gene silencing, delivered to hearing-related cells via a vector. It does not repair the original gene or change inherited genes. Gene therapy cannot address all types of genetic hearing loss, and choosing it is a personal decision.
- What is available and what is being studied: As of April 2026, accelerated approval was granted for a gene addition therapy for hearing loss related to the otoferlin (OTOF) gene. Studies for other OTOF gene therapies and GJB2-related hearing loss are underway.
- Considering whether gene therapy is for you: Eligibility depends on factors like age, hearing levels, the condition of inner ear cells, ear anatomy, and previous treatment. Before agreeing to gene therapy, you should understand the benefits, uncertainties, follow-up requirements, impact on other treatments, cost, and whether travel to a specialized facility is needed.
What is gene therapy?
Gene therapy is a new technology that addresses the root cause rather than symptoms of hearing loss caused by one of the many genes related to hearing.
How do genes and your hearing work?
The genes inside each cell of your body provide instructions that help the cell do its job. Some genes provide instructions to cells in the inner ear that help you detect sound and send signals to your brain. A change in one of these genes, called a variant, can affect this process.
If a genetic variation is suspected as the cause of hearing loss, genetic testing can identify the specific gene(s) involved. A confirmed genetic diagnosis can help a care team assess whether a particular gene therapy or research study might be relevant. Testing does not commit anyone to treatment.
How gene therapy works
Gene therapy can take several forms:
- Gene addition (also called gene supplementation) delivers a working copy of a gene to cells
- Gene editing makes changes only to specific sequences of the DNA of cells involved in hearing
- Gene silencing does not change the DNA of a cell, but stops the cell from following the instructions of a dysfunctional or harmful gene
In each case, genetic material is delivered to the cells that help a patient hear. The delivery mechanism (or vector) varies depending on the method. In gene addition, for example, a harmless virus acts as a biological suitcase, delivering a healthy version of a gene to a patient’s cells.
No gene therapy can repair the person’s original gene or grow new hearing cells. It also does not change the genes a person passes on to their children. Gene therapy does not treat every type of hearing loss and choosing whether to explore it is a personal decision.
What is available and what is being studied?
In April 2026, the U.S. Food and Drug Administration granted accelerated approval to a gene addition therapy for hearing loss related to the otoferlin (OTOF) gene. In the Spring 2026 issue of Hearing Life magazine, Dr. Eliot Shearer, M.D., Ph.D., noted that “while not all patients [in the clinical trials] recover hearing completely, the majority are no longer candidates for cochlear implantation, as their natural hearing has been restored.” Continued approval depends on further evidence about its benefits over time.
Other OTOF gene therapies are being studied, and researchers are developing treatments for hearing loss caused by another gene, colloquially called GJB2. Some approaches are conducting human trials, while others remain focused on laboratory research.
Benefits, risks, and questions
Gene therapies for hearing loss are still relatively new. Results vary, and researchers continue to study how long benefits last and how they differ across demographic groups.
The risks associated with gene therapy depend on the treatment and delivery method. They may include inflammation, immune reactions, dizziness, gait disturbance, infection, pain, and complications of surgery or anesthesia. There may also be risks that are not yet known. Follow-up visits and hearing tests help assess both safety and benefit over time. That’s why we continue to encourage everyone to be an equal partner in their treatment by asking questions early and often of their healthcare providers.
Considering your options
Eligibility for gene therapy depends on more than the results of genetic testing. A specialist team may consider age, hearing levels, the condition of inner ear cells, ear anatomy, and previous treatment. (For example, having a cochlear implant may affect eligibility in that ear.)
Before you agree to gene therapy, make sure you understand:
- What benefits are realistic
- What remains uncertain
- What the short- and long-term follow-up should be from you and your healthcare providers
- How treatment might affect other treatment options for your hearing loss
- How much gene therapy costs and what your insurance will cover
- Whether you will have to travel to a facility that conducts the therapy
If you are participating in a clinical trial or study, make sure the research team explains the rules of participation and withdrawal before you agree to join.
Additional Resources
- Watch our educational webinar about genetic hearing loss, “The Information We Carry”
- Meet and talk with parents of children with genetic hearing loss through our Genetic Connection peer support group